Clinical trial and local process evaluation of an apheresis system for preparation of white cell-reduced platelet components

被引:8
作者
Adams, MR
Dumont, LJ
McCall, M
Heaton, WA
机构
[1] Irwin Mem Blood Ctr, Blood Ctr Pacific, Dept Med, San Francisco, CA 94118 USA
[2] COBE BCT Inc, Lakewood, CO USA
关键词
D O I
10.1046/j.1537-2995.1998.381098440862.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: A new method for the consistent preparation of white cell (WBC)-reduced plateletpheresis components, the Spectra Leukoreduction System (LRS), was evaluated by clinical trial and local process validation. The centrifuge-based system was projected to decrease the WBC content of plateletpheresis components to a level below 1 x 10(6) per unit. Phase I and II clinical trials were performed. The manufacturer's claims were then tested at the local level with an ongoing quality assurance program. STUDY DESIGN AND METHODS: In Phase I, a crossover analysis of five subjects compared LRS to standard plateletpheresis procedures in collection efficiency and component quality: a panel of in vitro measures was taken on Day 0 and Day 5. In Phase II, the LRS process was tested on a larger scale (n = 57; control = 58) with component transfusion. Finally, validation, determination of degree of conformance with standards, and ongoing quality control were performed locally on a newly installed instrument. RESULTS: Phase I and II trials revealed no significant differences between LRS and control units in donor or recipient safety and comfort, platelet function and yield, or component volume. WBC per-unit values were significantly different: the LRS median per unit was 3.2 x 10(4) WBCs, versus 81.4 x 10(4) for control units. Assessment of process capability gave an estimate of gs-percent confidence that 99.5 percent of LRS units would be WBC reduced to <1 x 10(6) WBCs. Local process validation and quality control revealed 90-percent confidence that 99 percent of the units would be WBC reduced and 99.9-percent confidence that 75 percent would exceed platelet yield standards; the process was stable over time. CONCLUSIONS: The LRS is safe for apheresis and the component produced is safe for transfusion with platelet function and yield equivalent to controls and WBC reduction superior to controls. Local process evaluation confirmed that component quality meets the goals of the institution.
引用
收藏
页码:966 / 974
页数:9
相关论文
共 31 条
[1]   THE EFFECTS OF OSMOTIC-STRESS ON HUMAN-PLATELETS [J].
ARMITAGE, WJ ;
PARMAR, N ;
HUNT, CJ .
JOURNAL OF CELLULAR PHYSIOLOGY, 1985, 123 (02) :241-248
[2]   EFFECT OF FILTRATION OF PLATELET CONCENTRATES ON THE ACCUMULATION OF CYTOKINES AND PLATELET-RELEASE FACTORS DURING STORAGE [J].
AYE, MT ;
PALMER, DS ;
GIULIVI, A ;
HASHEMI, S .
TRANSFUSION, 1995, 35 (02) :117-124
[3]  
BLAJCHMAN MA, 1992, BLOOD, V79, P1371
[4]   THE TUMOR GROWTH-PROMOTING EFFECT OF ALLOGENEIC BLOOD-TRANSFUSIONS [J].
BLAJCHMAN, MA ;
BORDIN, JO .
IMMUNOLOGICAL INVESTIGATIONS, 1995, 24 (1-2) :311-317
[5]   EXPERIMENTAL ANIMAL-MODEL OF REFRACTORINESS TO DONOR PLATELETS - THE EFFECT OF PLASMA REMOVAL AND THE EXTENT OF WHITE CELL-REDUCTION ON ALLOGENEIC ALLOIMMUNIZATION [J].
BORDIN, JO ;
BARDOSSY, L ;
BLAJCHMAN, MA .
TRANSFUSION, 1993, 33 (10) :798-801
[6]   A COMPARISON OF FILTERED LEUKOCYTE-REDUCED AND CYTOMEGALOVIRUS (CMV) SERONEGATIVE BLOOD PRODUCTS FOR THE PREVENTION OF TRANSFUSION-ASSOCIATED CMV INFECTION AFTER MARROW TRANSPLANT [J].
BOWDEN, RA ;
SLICHTER, SJ ;
SAYERS, M ;
WEISDORF, D ;
CAYS, M ;
SCHOCH, G ;
BANAJI, M ;
HAAKE, R ;
WELK, K ;
FISHER, L ;
MCCULLOUGH, J ;
MILLER, W .
BLOOD, 1995, 86 (09) :3598-3603
[7]  
BUSCH MP, 1992, BLOOD, V80, P2128
[8]   More on kininogen measurements in platelet concentrates that are white cell (WBC) reduced with WBC-reduction filters [J].
Colman, RW ;
Scott, CF ;
Brandwein, H ;
Whitbread, J .
TRANSFUSION, 1996, 36 (10) :939-940
[9]   PREVENTION OF PRIMARY CYTOMEGALOVIRUS-INFECTION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION BY USING LEUKOCYTE-POOR RANDOM BLOOD PRODUCTS FROM CYTOMEGALOVIRUS-UNSCREENED BLOOD-BANK DONORS [J].
DEWITTE, T ;
SCHATTENBERG, A ;
VANDIJK, BA ;
GALAMA, J ;
OLTHUIS, H ;
VANDERMEER, JWW ;
KUNST, VAJM .
TRANSPLANTATION, 1990, 50 (06) :964-968
[10]  
DIEM K, 1982, GEIGY SCI TABLES, V2, P52